MedPath

合肥华方医药科技有限公司

Ownership
-
Established
2003-12-01
Employees
-
Market Cap
-
Website
www.huafangpharm.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

NMPA:9

Drug Approvals

Nifedipine Controlled-release Tablets

Product Name
硝苯地平控释片
Approval Number
国药准字H20234152
Approval Date
Sep 12, 2023
NMPA

Venlafaxine Hydrochloride Sustained-release Tablets

Product Name
盐酸文拉法辛缓释片
Approval Number
国药准字H20203741
Approval Date
Dec 29, 2020
NMPA

冻干蜂王浆胶囊

Approval Number
国药准字Z20027565
Approval Date
Dec 15, 2020
NMPA

普乐安片

Approval Number
国药准字Z34021018
Approval Date
Dec 15, 2020
NMPA

Proplis Tablets

Product Name
蜂胶片
Approval Number
国药准字H34022278
Approval Date
Dec 15, 2020
NMPA

乳宁胶囊

Approval Number
国药准字Z20080443
Approval Date
Sep 7, 2020
NMPA

心舒宝胶囊

Approval Number
国药准字Z20080161
Approval Date
Sep 7, 2020
NMPA

糖尿乐片

Approval Number
国药准字Z20080442
Approval Date
Sep 7, 2020
NMPA

调经袪斑片

Approval Number
国药准字Z20150047
Approval Date
Jun 18, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.